Document is current
Any future updates will be listed below
-
Authors
Aggarwal, Arpit https://orcid.org/0009-0001-3253-7270
Khalighi, Sirvan
Babu, Deepak
Li, Haojia https://orcid.org/0000-0001-5000-5334
Azarianpour-Esfahani, Sepideh https://orcid.org/0000-0002-3659-9751
Corredor, Germán https://orcid.org/0000-0003-3002-0937
Fu, Pingfu https://orcid.org/0000-0002-2334-5218
Mokhtari, Mojgan
Pathak, Tilak
Thayer, Elizabeth https://orcid.org/0000-0002-8800-5273
Modesitt, Susan
Mahdi, Haider
Avril, Stefanie
Madabhushi, Anant https://orcid.org/0000-0002-5741-0399
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA202752-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA208236-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA216579-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 18 July 2023
Accepted: 13 December 2023
First Online: 3 January 2024
Competing interests
: The authors declare the following competing interests: A.M. is an equity holder in Picture Health, Elucid Bioimaging, and Inspirata Inc. Currently he serves on the advisory board of Picture Health, Aiforia Inc, and SimBioSys. He also currently consults for SimBioSys. He also has sponsored research agreements with AstraZeneca, Boehringer-Ingelheim, Eli-Lilly and Bristol Myers-Squibb. His technology has been licensed to Picture Health and Elucid Bioimaging. He is also involved in 3 different R01 grants with Inspirata Inc. He also serves as a member for the Frederick National Laboratory Advisory Committee.
